Search

Sort Results

Search results

Current filters: HIV drugs, HIV

164 search results

Agencies issue caution about use of dolutegravir by pregnant HIV-positive women

2018, CATIE
Research summary - Webpage

Symtuza approved in Canada for treatment of HIV

2018, CATIE
Research summary - Webpage

Dutch study ties HIV to erection problems in middle-aged men

2018, CATIE
Research summary - Webpage

Winnipeg doctors use dolutegravir and darunavir for simplifying treatment

2018, CATIE
Research summary - Webpage

Preliminary results of dolutegravir + 3TC for initial therapy of HIV

From TreatmentUpdate 224
2018, CATIE
Research summary - Webpage

Dolutegravir + 3TC as maintenance therapy—a pilot study

From TreatmentUpdate 224
2018, CATIE
Research summary - Webpage

Dolutegravir + rilpivirine as maintenance therapy

From TreatmentUpdate 224
2018, CATIE
Research summary - Webpage

The re-emergence of dual therapy

From TreatmentUpdate 224
2018, CATIE
Research summary - Webpage

What’s next for long-acting HIV drugs?

From TreatmentUpdate 222
2017, CATIE
Research summary - Webpage

Long-acting drugs for HIV

From TreatmentUpdate 222
2017, CATIE
Research summary - Webpage